Literature DB >> 6383672

Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.

S W Zimmerman.   

Abstract

Proteinuria and nephrotic syndrome due to recurrent disease may develop after renal transplant in patients with focal glomerular sclerosis (FGS). The rapid onset of proteinuria in many of these patients suggests a possible humoral mediator. We studied serum from a patient who has had recurrence of nephrotic syndrome and FGS after two cadaveric renal allografts to determine if a serum factor capable of producing increased urinary protein excretion was present. Serum was infused into the aorta of anesthetized rats. During infusion of serum from the patient with recurrent FGS, there were significant increases in mean urinary protein and rat albumin excretion which persisted after infusion. When sera from ten patients with nephrotic syndrome secondary to other glomerulopathies were infused no changes in urinary protein or albumin excretion were noted. Likewise no changes in urine protein or albumin excretion were produced with infusion of serum from a patient with FGS without recurrence after transplantation. Increases in urine protein and albumin excretion noted during and after infusion of recurrent FGS serum were independent of changes in glomerular filtration rate, urine volume, or fractional excretion of sodium. These results suggest there is a factor or factors present in the serum of this patient capable of producing enhanced urinary protein excretion in the rat. This factor(s) which is heat stable at 56 degrees C could possibly play a role in the pathogenesis of recurrent nephrotic syndrome.

Entities:  

Mesh:

Year:  1984        PMID: 6383672

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  37 in total

Review 1.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

2.  Relapse of nephrotic syndrome, progressive renal failure and return to chronic dialysis therapy after a renal transplant.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 3.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

4.  Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.

Authors:  A Meyrier; P Simon; G Perret; M C Condamin-Meyrier
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

Review 5.  Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.

Authors:  A Meyrier
Journal:  Springer Semin Immunopathol       Date:  1987

Review 6.  Genetics of childhood steroid-sensitive nephrotic syndrome.

Authors:  Alana M Karp; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2016-07-29       Impact factor: 3.714

Review 7.  Extrarenal determinants of kidney filter function.

Authors:  Eunsil Hahm; Vasil Peev; Jochen Reiser
Journal:  Cell Tissue Res       Date:  2017-05-30       Impact factor: 5.249

8.  Early use of plasmapheresis for recurrent post-transplant FSGS.

Authors:  Madhura Pradhan; Julie Petro; Joanne Palmer; Kevin Meyers; H Jorge Baluarte
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

Review 9.  Treatment of steroid-resistant nephrotic syndrome in the genomic era.

Authors:  Adam R Bensimhon; Anna E Williams; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2018-10-02       Impact factor: 3.714

10.  Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

Authors:  P Cochat; A Kassir; S Colon; C Glastre; B Tourniaire; B Parchoux; X Martin; L David
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.